PubMed

Comparison of Lipid and Fatty Acid Composition of the Liver, Subcutaneous and Intra-abdominal Adipose Tissue, and Serum.

Kotronen A, Seppänen-Laakso T, Westerbacka J, Kiviluoto T, Arola J, Ruskeepää AL, Yki-Järvinen H, Orešič M.

Obesity (Silver Spring). 2009 Oct 1. [Epub ahead of print]PMID: 19798063 [PubMed - as supplied by publisher]Related articles

Liver fat and lipid oxidation in humans.

Kotronen A, Seppälä-Lindroos A, Vehkavaara S, Bergholm R, Frayn KN, Fielding BA, Yki-Järvinen H.

Liver Int. 2009 Oct;29(9):1439-46. Epub 2009 Jul 7.PMID: 19602132 [PubMed - indexed for MEDLINE]Related articles

Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors.

Kotronen A, Peltonen M, Hakkarainen A, Sevastianova K, Bergholm R, Johansson LM, Lundbom N, Rissanen A, Ridderstråle M, Groop L, Orho-Melander M, Yki-Järvinen H.

Gastroenterology. 2009 Sep;137(3):865-72. Epub 2009 Jun 12.PMID: 19524579 [PubMed - indexed for MEDLINE]Related articles

Nateglinide combination therapy with basal insulin and metformin in patients with Type 2 diabetes.

Juurinen L, Tiikkainen M, Saltevo J, Nikkilä K, Lanki H, Leppävuori E, Kock T, Teikari-Myyrä T, Kauppinen-Mäkelin R, Kotronen A, Yki-Järvinen H.

Diabet Med. 2009 Apr;26(4):409-15.PMID: 19388972 [PubMed - indexed for MEDLINE]Related articles

A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans.

Kotronen A, Johansson LE, Johansson LM, Roos C, Westerbacka J, Hamsten A, Bergholm R, Arkkila P, Arola J, Kiviluoto T, Fisher RM, Ehrenborg E, Orho-Melander M, Ridderstråle M, Groop L, Yki-Järvinen H.

Diabetologia. 2009 Jun;52(6):1056-60. Epub 2009 Feb 18.PMID: 19224197 [PubMed - indexed for MEDLINE]Related articles

Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations.

Kotronen A, Velagapudi VR, Yetukuri L, Westerbacka J, Bergholm R, Ekroos K, Makkonen J, Taskinen MR, Oresic M, Yki-Järvinen H.

Diabetologia. 2009 Apr;52(4):684-90. Epub 2009 Feb 13.PMID: 19214471 [PubMed - indexed for MEDLINE]Related articles

Genetic variation in the ADIPOR2 gene is associated with liver fat content and its surrogate markers in three independent cohorts.

Kotronen A, Yki-Järvinen H, Aminoff A, Bergholm R, Pietiläinen KH, Westerbacka J, Talmud PJ, Humphries SE, Hamsten A, Isomaa B, Groop L, Orho-Melander M, Ehrenborg E, Fisher RM.

Eur J Endocrinol. 2009 Apr;160(4):593-602. Epub 2009 Feb 10.PMID: 19208777 [PubMed - indexed for MEDLINE]Related articles

Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver.

Kotronen A, Seppänen-Laakso T, Westerbacka J, Kiviluoto T, Arola J, Ruskeepää AL, Oresic M, Yki-Järvinen H.

Diabetes. 2009 Jan;58(1):203-8. Epub 2008 Oct 24.PMID: 18952834 [PubMed - indexed for MEDLINE]Related articlesFree article

Insulin-like growth factor binding protein 1 as a novel specific marker of hepatic insulin sensitivity.

Kotronen A, Lewitt M, Hall K, Brismar K, Yki-Järvinen H.

J Clin Endocrinol Metab. 2008 Dec;93(12):4867-72. Epub 2008 Sep 16.PMID: 18796514 [PubMed - indexed for MEDLINE]Related articles

Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.

Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki-Järvinen H.

Gastroenterology. 2008 Jul;135(1):122-30. Epub 2008 Mar 21.PMID: 18474251 [PubMed - indexed for MEDLINE]Related articles

Gene expression in human NAFLD.

Greco D, Kotronen A, Westerbacka J, Puig O, Arkkila P, Kiviluoto T, Laitinen S, Kolak M, Fisher RM, Hamsten A, Auvinen P, Yki-Järvinen H.

Am J Physiol Gastrointest Liver Physiol. 2008 May;294(5):G1281-7. Epub 2008 Apr 3.PMID: 18388185 [PubMed - indexed for MEDLINE]Related articlesFree article

Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation.

Tammela T, Saaristo A, Holopainen T, Lyytikkä J, Kotronen A, Pitkonen M, Abo-Ramadan U, Ylä-Herttuala S, Petrova TV, Alitalo K.

Nat Med. 2007 Dec;13(12):1458-66. Epub 2007 Dec 2.PMID: 18059280 [PubMed - indexed for MEDLINE]Related articles

Tissue specificity of insulin resistance in humans: fat in the liver rather than muscle is associated with features of the metabolic syndrome.

Kotronen A, Seppälä-Lindroos A, Bergholm R, Yki-Järvinen H.

Diabetologia. 2008 Jan;51(1):130-8. Epub 2007 Nov 16.PMID: 18008059 [PubMed - indexed for MEDLINE]Related articles

Rosiglitazone reduces liver fat and insulin requirements and improves hepatic insulin sensitivity and glycemic control in patients with type 2 diabetes requiring high insulin doses.

Juurinen L, Kotronen A, Granér M, Yki-Järvinen H.

J Clin Endocrinol Metab. 2008 Jan;93(1):118-24. Epub 2007 Oct 23.PMID: 17956948 [PubMed - indexed for MEDLINE]Related articlesFree article

Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects.

Kotronen A, Juurinen L, Hakkarainen A, Westerbacka J, Cornér A, Bergholm R, Yki-Järvinen H.

Diabetes Care. 2008 Jan;31(1):165-9. Epub 2007 Oct 12.PMID: 17934148 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of liver fat on insulin clearance.

Kotronen A, Vehkavaara S, Seppälä-Lindroos A, Bergholm R, Yki-Järvinen H.

Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1709-15. Epub 2007 Sep 25.PMID: 17895288 [PubMed - indexed for MEDLINE]Related articlesFree article

Fatty liver: a novel component of the metabolic syndrome.

Kotronen A, Yki-Järvinen H.

Arterioscler Thromb Vasc Biol. 2008 Jan;28(1):27-38. Epub 2007 Aug 9. Review.PMID: 17690317 [PubMed - indexed for MEDLINE]Related articlesFree article

Liver fat in the metabolic syndrome.

Kotronen A, Westerbacka J, Bergholm R, Pietiläinen KH, Yki-Järvinen H.

J Clin Endocrinol Metab. 2007 Sep;92(9):3490-7. Epub 2007 Jun 26.PMID: 17595248 [PubMed - indexed for MEDLINE]Related articlesFree article